trans-10,cis-12 conjugated linoleic acid inhibits the G1-S cell cycle progression in DU145 human prostate carcinoma cells

Journal of Medicinal Food

Volumn 9, Issue 3, 2006, Pages 293-299

  Eun, Ji Kim ^a   Shin, Hyun Kyung ^a   Jin, Sun Cho ^a   Sang, Kon Lee ^a   Moo, Ho Won ^a   Jong, Woo Kim ^b   Park, Jung Han Yoon ^a  

^a Hallym University   (South Korea)

^b Pohang St Mary's Hospital   (South Korea)

Author keywords

Cell cycle; cis 9,trans 11 conjugated linoleic acid; DU145 cells; Prostate cancer cells; trans 10,cis 12 conjugated linoleic acid

Indexed keywords

10,12 CONJUGATED LINOLEIC ACID; 9,11 CONJUGATED LINOLEIC ACID; CELL CYCLE PROTEIN; CONJUGATED LINOLEIC ACID; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CIS 9, TRANS 11 CONJUGATED LINOLEIC ACID; CIS-9, TRANS-11-CONJUGATED LINOLEIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TRANS 10,CIS 12 CONJUGATED LINOLEIC ACID; TRANS-10,CIS-12-CONJUGATED LINOLEIC ACID;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONCENTRATION RESPONSE; ENZYME ASSAY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; WESTERN BLOTTING; CELL DIVISION; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALIA;

BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; HUMANS; LINOLEIC ACIDS, CONJUGATED; MALE; PROSTATIC NEOPLASMS; S PHASE;

EID: 33750612531     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.293     Document Type: Article

References (31)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Cohen LA: Nutrition and prostate cancer: a review. Ann N Y Acad Sci 2002;963:148-155.
3. Scimeca JA: Toxicological evaluation of dietary conjugated linoleic acid in male Fischer 344 rats. Food Chem Toxicol 1998; 36:391-395.
4. Ha YL, Grimm NK, Pariza MW: Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 1987;8:1881-1887.
5. Belury MA: Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002;132:2995-2998.
6. Shultz TD, Chew BP, Seaman WR, Luedecke LO: Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett 1992;63:125-133.
7. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, Lee HS, Tyner AL, Park JHY: Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 2003;284:G996-G1005.
8. Oh YS, Lee HS, Cho HJ, Lee SG, Jung KC, Park JHY: Conjugated linoleic acid inhibits DNA synthesis and induces apoptosis in TSU-Pr1 human bladder cancer cells. Anticancer Res 2003;23: 4765-4772.
9. Song HJ, Sneddon AA, Barker PA, Bestwick C, Choe SN, McClinton S, Grant I, Rotondo D, Keys SD, Wahle KW: Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr Cancer 2004;49: 100-108.
10. Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677.
11. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
12. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
13. Mueller A, Odze R, Jenkins TD, Shahsesfaei A, Nakagawa H, Inomoto T, Rustgi AK: A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities. Cancer Res 1997;57:5542-5549.
14. Guadagno TM, Newport JW: Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 1996;84:73-82.
15. Elledge SJ, Harper JW: Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 1994;6:847-852.
16. Grana X, Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-219.
17. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-704.
18. Datto MB, Yu Y, Wang XF: Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 1995;270:28623-28628.
19. Choi YH, Lee WH, Park KY, Zhang L: p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn J Cancer Res 2000;91:164-173.
20. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-825.
21. Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995;9:639-649.
22. Hong C, Kim HA, Firestone GL, Bjeldanes LF: 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002;23:1297-1305.
23. Choi YH, Zhang L, Lee WH, Park KY: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 1998;13:391-396.
24. Kim EJ, Kim WY, Kang YH, Ha YL, Bach L, Park JHY: Inhibition of Caco-2 cell proliferation by (n-3) fatty acids: possible mediation by increased secretion of insulin-like growth factor binding protein-6. Nutr Res 2000;20:1409-1421.
25. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival: modifications of the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89:271-277.
26. Lim DY, Tyner AL, Park JB, Lee JY, Choi YH, Park JHY: Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21(CIP1/WAF1). J Cell Physiol 2005;205:107-113.
27. Lee KW, Lee HJ, Cho HY, Kim YJ: Role of the conjugated linoleic acid in the prevention of cancer. Crit Rev Food Sci Nutr 2005;45:135-144.
28. Cesano A, Visonneau S, Scimeca JA, Kritchevsky D, Santoli D: Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998;18: 1429-1434.
29. Cohen LA, Zhao Z, Pittman B, Scimeca J: Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors. Prostate 2003;54:169-180.
30. Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD, Wahle KW: Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 2004;25:1185-1191.
31. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.